表紙
市場調查報告書
商品編碼
1028797

生物相似藥的全球市場分析 (2021年):新型冠狀病毒感染疾病 (COVID-19)下的成長和變化 (2030年)

Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球生物相似藥的市場結構·趨勢相關分析,提供市場的主要特徵·結構,及整體市場規模·成長率趨勢預測,各市場區隔 (各產品·各用途) 及地區別·主要國家詳細趨勢,主要企業的簡介,近幾年的主要趨勢,今後的市場機會等調查。

目錄

第1章 摘要整理

第2章 生物相似藥市場特徵

第3章 生物相似藥市場趨勢與策略

第4章 新型冠狀病毒感染疾病 (COVID-19)對生物相似藥市場的影響

第5章 生物相似藥市場:市場規模·成長率

  • 市場規模 (單位:10億美元,2015年∼2020年)
    • 推動市場要素
    • 阻礙市場要素
  • 市場規模 (單位:10億美元,2020年∼2025年,2030年)
    • 推動市場要素
    • 阻礙市場要素

第6章 生物相似藥市場:各領域分析

  • 各產品的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)
  • 重組非糖基化蛋白質
  • 重組糖基化蛋白質
  • 不同種類的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)
  • 人體生長荷爾蒙
  • 促血紅細胞生長素
  • 單株抗體
  • 胰島素
  • 干擾素
  • 顆粒球 - 細胞聚落刺激因子 (G-CSF)
  • 其他
  • 各用途的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)
  • 腫瘤
  • 慢性疾病,自體免疫疾病
  • 生長激素缺乏症
  • 感染疾病
  • 其他

第7章 生物相似藥市場:各地區·各國分析

  • 各地區的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)
  • 各國市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)

第8章 亞太地區的生物相似藥市場

  • 市場概要
  • 地區資訊
  • 各產品的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)
  • 各用途的市場規模 (單位:10億美元,2015年∼2020年/2020年∼2025年/2030年)

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐的生物相似藥市場

第16章 英國市場

第17章 德國市場

第18章 法國市場

第19章 東歐的生物相似藥市場

第20章 俄羅斯市場

第21章 北美的生物相似藥市場

第22章 美國市場

第23章 南美的生物相似藥市場

第24章 巴西市場

第25章 中東的生物相似藥市場

第26章 非洲的生物相似藥市場

第27章 生物相似藥市場:競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Pfizer
    • Amgen
    • Biocon
    • Celltrion
    • Dr. Reddy's Laboratories

第28章 生物相似藥的開發中產品分析

第29章 生物相似藥市場上主要企業合併·收購 (M&A)

第30章 生物相似藥市場:未來展望與潛在力分析

第31章 附錄

目錄
Product Code: h821

“Biosimilars Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilars market.

This report focuses on biosimilars market which is experiencing strong growth. The report gives a guide to the biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Biosimilars market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilars market section of the report gives context. It compares the biosimilars market with other segments of the biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilars indicators comparison.

Scope

Markets Covered:

1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins

2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others

3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others

Companies Mentioned: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilars Market Characteristics

3. Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilars

5. Biosimilars Market Size And Growth

  • 5.1. Global Biosimilars Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilars Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilars Market Segmentation

  • 6.1. Global Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Recombinant Non-glycosylated Proteins
  • Recombinant Glycosylated Proteins
  • 6.2. Global Biosimilars Market, Segmentation By Types, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Others
  • 6.3. Global Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Others

7. Biosimilars Market Regional And Country Analysis

  • 7.1. Global Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Biosimilars Market

  • 8.1. Asia-Pacific Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Biosimilars Market

  • 9.1. China Biosimilars Market Overview
  • 9.2. China Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Biosimilars Market

  • 10.1. India Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Biosimilars Market

  • 11.1. Japan Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Biosimilars Market

  • 12.1. Australia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Biosimilars Market

  • 13.1. Indonesia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Biosimilars Market

  • 14.1. South Korea Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Biosimilars Market

  • 15.1. Western Europe Biosimilars Market Overview
  • 15.2. Western Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Biosimilars Market

  • 16.1. UK Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Biosimilars Market

  • 17.1. Germany Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Biosimilars Market

  • 18.4. France Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Biosimilars Market

  • 19.1. Eastern Europe Biosimilars Market Overview
  • 19.2. Eastern Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Biosimilars Market

  • 20.1. Russia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Biosimilars Market

  • 21.1. North America Biosimilars Market Overview
  • 21.2. North America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Biosimilars Market

  • 22.1. USA Biosimilars Market Overview
  • 22.2. USA Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Biosimilars Market

  • 23.1. South America Biosimilars Market Overview
  • 23.2. South America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Biosimilars Market

  • 24.1. Brazil Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Biosimilars Market

  • 25.1. Middle East Biosimilars Market Overview
  • 25.2. Middle East Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Biosimilars Market

  • 26.1. Africa Biosimilars Market Overview
  • 26.2. Africa Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilars Market Competitive Landscape
  • 27.2. Biosimilars Market Company Profiles
    • 27.2.1. Pfizer
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Amgen
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Biocon
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Celltrion
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Dr. Reddy's Laboratories
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilars Market

30. Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer